ReviewFrontiers in medicine2021

Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge.

Michele Provenzano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.